These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 6224436)
1. Demonstration of a subpopulation of Ia+ T-helper cells in mycosis fungoides and the Sézary syndrome. Hofman FM; Meyer PR; Yanagihara E; Modlin RL; Rea TH; Parker JW; Lukes RJ; Taylor CR Am J Dermatopathol; 1983 Apr; 5(2):135-43. PubMed ID: 6224436 [TBL] [Abstract][Full Text] [Related]
2. [Cells in the epidermotropic lymphomas (mycosis fungoides and Sézary syndrome. Study using monoclonal antibodies]. Thivolet J; Schmitt D; Souteyrand P; Brochier J Nouv Presse Med; 1982 Oct; 11(41):3033-8. PubMed ID: 6755391 [TBL] [Abstract][Full Text] [Related]
4. T cell subset heterogeneity in a series of patients with mycosis fungoides and Sézary syndrome. Piepkorn M; Marty J; Kjeldsberg CR J Am Acad Dermatol; 1984 Sep; 11(3):427-32. PubMed ID: 6237132 [TBL] [Abstract][Full Text] [Related]
5. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions. Schmitt D; Thivolet J J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276 [TBL] [Abstract][Full Text] [Related]
7. Disseminated pagetoid reticulosis associated with mycosis fungoides: immunomorphologic study. Lacour JP; Juhlin L; el Baze P; Barety M; Ortonne JP J Am Acad Dermatol; 1986 May; 14(5 Pt 2):898-901. PubMed ID: 2940272 [TBL] [Abstract][Full Text] [Related]
8. The intracutaneous growth of murine lymphomas: epidermal invasion is characteristic of multiple tumor phenotypes. Piepkorn M; Tigelaar RE J Invest Dermatol; 1984 Oct; 83(4):281-5. PubMed ID: 6237158 [TBL] [Abstract][Full Text] [Related]
9. Clinical and Histological Characteristics of Mycosis Fungoides and Sézary Syndrome: A Retrospective, Single-centre Study of 43 Patients from Eastern Denmark. Nielsen PR; Eriksen JO; Wehkamp U; Lindahl LM; Gniadecki R; Fogh H; Fabricius S; Bzorek M; Ødum N; Gjerdrum LM Acta Derm Venereol; 2019 Dec; 99(13):1231-1236. PubMed ID: 31620804 [TBL] [Abstract][Full Text] [Related]
10. Predominant cutaneous infiltration by OKT6- and OKT8-positive cells in a case of Sézary syndrome. Meissner K; Löning T; Heckmayr M; Zschaber R; Jänner M Arch Dermatol Res; 1983; 275(3):168-74. PubMed ID: 6351762 [TBL] [Abstract][Full Text] [Related]
11. Phenotype of cells involved in mycosis fungoides and Sézary syndrome (blood and skin lesions): immunomorphological study with monoclonal antibodies. Schmitt D; Souteyrand P; Brochier J; Czernielewski J; Thivolet J Acta Derm Venereol; 1982; 62(3):193-9. PubMed ID: 6179357 [TBL] [Abstract][Full Text] [Related]
12. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study. Sigurdsson V; Toonstra J; Bihari IC; Bruijnzeel-Koomen CA; van Vloten WA; Thepen T J Cutan Pathol; 2000 Oct; 27(9):429-35. PubMed ID: 11028812 [TBL] [Abstract][Full Text] [Related]
13. Cutaneous T cell lymphoma differing from classical mycosis fungoides and Sézary syndrome: clinical, histological and immunohistochemical studies of six cases. Maeda K; Takahashi M; Takatsuka N; Miyazawa H J Dermatol; 1990 Apr; 17(4):226-34. PubMed ID: 2195088 [TBL] [Abstract][Full Text] [Related]
14. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome. Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128 [TBL] [Abstract][Full Text] [Related]
15. Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping. Pulitzer MP; Horna P; Almeida J Cytometry B Clin Cytom; 2021 Mar; 100(2):132-138. PubMed ID: 32516521 [TBL] [Abstract][Full Text] [Related]
16. New aspects of the clinicopathological features and treatment of mycosis fungoides and Sézary syndrome. Furue M; Kadono T J Dermatol; 2015 Oct; 42(10):941-4. PubMed ID: 26432429 [TBL] [Abstract][Full Text] [Related]
17. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment. Hoppe RT; Wood GS; Abel EA Curr Probl Cancer; 1990; 14(6):293-371. PubMed ID: 2245651 [TBL] [Abstract][Full Text] [Related]
18. Nuclear contour irregularity correlates with Leu-9-, Leu-8- cells in benign lymphoid infiltrates of skin. An ultrastructural morphometric and quantitative immunophenotypic analysis suggesting the normal T-cell counterpart to the malignant mycosis fungoides/Sézary cell. Payne CM; Spier CM; Grogan TM; Richter LC; Bjore CG; Cromey DW; Rangel CS Am J Dermatopathol; 1988 Oct; 10(5):377-89. PubMed ID: 3265861 [TBL] [Abstract][Full Text] [Related]
19. Mycosis fungoides/Sezary's syndrome progressing to immunoblastic sarcoma. A T-cell lymphoproliferation with both helper and suppressor phenotypes. Yanagihara ET; Parker JW; Meyer PR; Cain MJ; Hofman F; Lukes RJ Am J Clin Pathol; 1984 Feb; 81(2):249-57. PubMed ID: 6230003 [TBL] [Abstract][Full Text] [Related]
20. Immunoelectron microscopy related to T-cell monoclonal surface antigen in mycosis fungoides. Hashimoto K; Iwahara K Am J Dermatopathol; 1983 Apr; 5(2):129-34. PubMed ID: 6224435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]